Search clinical trials for: Vorapaxar and Clopidogrel

Total 271565 results

Inova Health Care Services
Merck Sharp & Dohme LLC

Completed

Vorapaxar on Thrombin Generation and Coagulability

Myocardial Infarction | Coronary Artery Disease | Peripheral Vascular Disease

United States
Ken Mahaffey
Merck Sharp & Dohme LLC

Completed

Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access

AV Fistula

United States
Kirby Institute
National Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp... and other collaborators

Completed

Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints (ADVICE)

HIV

Australia, United States
Merck Sharp & Dohme LLC
Duke Clinical Research Institute; The TIMI (Thrombolysis in Myocardial Infarction)...

Completed

Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)

Myocardial Infarction | Ischemia | Atherosclerosis | Cerebrovascular Accident
Merck Sharp & Dohme LLC

Completed

Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573)

Coronary Disease | Arterial Obstructive Diseases
Merck Sharp & Dohme LLC
The Thrombolysis in Myocardial Infarction Study (TIMI) Group

Completed

Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)

Myocardial Infarction | Ischemia | Peripheral Arterial Disease | Atherosclerosis | Cerebrovascular Accident
Vanderbilt University
Merck Sharp & Dohme LLC

Withdrawn

Vorapaxar and Lower Extremity Bypass Grafts

Peripheral Artery Disease
Merck Sharp & Dohme LLC

Completed

A Bioequivalence Study of SCH 530348 2.5 mg Tablets (P06558)

Acute Coronary Syndrome
North Texas Veterans Healthcare System

Unknown

Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial) (XLPADTRACE)

Peripheral Arterial Disease

United States
Merck Sharp & Dohme LLC
Duke Clinical Research Institute

Terminated

Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)

Myocardial Infarction | Myocardial Ischemia | Atherosclerosis
Merck Sharp & Dohme LLC

Completed

Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017)

Cerebral Infarction
Medical University of Vienna

Completed

Vorapaxar in the Human Endotoxemia Model

Healthy Volunteers

Austria
University Hospital, Toulouse

Completed

TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement (TIRATROP)

Atherosclerosis

France
Korea University Anam Hospital

Completed

Method of Clopidogrel Pre-treatment Undergoing Conventional Coronary Angiogram in Angina Patients (MECCA)

Angina, Stable
Chinese PLA General Hospital

Unknown

Genotyping Guided Individualized Treatment of Clopidogrel and Ticagrelor in ACS (GI-CT)

CLOPIDOGREL, POOR METABOLISM of (Disorder)

China
Ospedale San Donato

Completed

Safety and Efficacy of Three Different Loading Doses of Clopidogrel, in Patients With Acute Myocardial Infarction (Load & Go)

Acute Myocardial Infarction

Italy
Takeda

Completed

A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

Healthy

United States
University of Pecs

Terminated

Doubling the Maintenance Dose of Clopidogrel in Patients With High On-Clopidogrel Platelet Reactivity (DOSER)

Stable Angina Pectoris | Ad Hoc Percutaneous Coronary Intervention

Hungary
Hospital Central San Luis Potosi, Mexico

Unknown

Patent Versus Generic Clopidogrel in Acute Coronary Syndrome

Acute Coronary Syndrome
University of North Carolina, Chapel Hill

Completed

Clopidogrel Pharmacogenomics Project

Disease Susceptibility

United States
Lady Reading Hospital, Pakistan
Pakistan Chest Society, Pakistan

Recruiting

Clopidogrel for the Prevention of Exacerbations in Severe COPD (CLOPEX)

COPD | COPD Exacerbation Acute

Pakistan
Deutsches Herzzentrum Muenchen

Terminated

Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES Implantation (ISAR-CAUTION)

Coronary Artery Disease

Germany
University of Florida
Merck Sharp & Dohme LLC

Completed

Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus (OPTIMUS-5)

Myocardial Infarction | Diabetes Mellitus | Peripheral Arterial Disease

United States
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Effectiveness of Clopidogrel Resinate in PCI(PRIDE)

Coronary Artery Disease

Korea, Republic of
University of Pecs
Hungarian Academy of Sciences; KRKA

Completed

Comparison of Generic and Original Formulation of Clopidogrel (DOSER-GENERIC)

Coronary Heart Disease | Percutaneous Coronary Intervention
Sir Run Run Shaw Hospital

Unknown

Effect of Different Anti-platelet Strategies on the Long-term Outcome After Sirolimus Drug-eluting Stent Implantation (EASTS)

Coronary Artery Disease
Ajou University School of Medicine
Dong-A Pharmaceutical

Completed

Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)

Acute Coronary Syndrome

Korea, Republic of
The Third Xiangya Hospital of Central South University

Completed

Study on the Registration of Coronary Heart Disease Patients Undergoing PCI

Coronary Heart Disease

China
Centre Hospitalier Universitaire de Saint Etienne

Completed

Investigation of Drug-drug Interaction Between Clopidogrel and Fluoxetine (PLATINE)

Healthy

France
University of Pecs

Completed

Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity (TREAT-HPR)

Acute Coronary Syndrome

Hungary
Merck Sharp & Dohme LLC

Completed

Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016)

Myocardial Infarction | Myocardial Ischemia | Atherosclerosis
Creighton University

Completed

The Impact of Grapefruit Juice on the Response to Clopidogrel

Healthy

United States
Khon Kaen University

Completed

Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products

Pharmacodynamics

Thailand
St. Antonius Hospital

Completed

Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation (POPular-TAVI)

Myocardial Infarction | Stroke | Bleeding | Aortic Valve Disease

Netherlands, Belgium, Czechia, Luxembourg
Korea University Anam Hospital

Completed

Genotyping Influences Outcome of Coronary Artery Stenting (GENIUS)

Myocardial Ischemia | CLOPIDOGREL, POOR METABOLISM of (Disorder)
Ruhr University of Bochum

Completed

Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan) (BOCLAplan)

Coronary Artery Disease

Germany
University Hospital Tuebingen

Completed

Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel

Peripheral Vascular Diseases

Germany
Sanofi
Bristol-Myers Squibb

Completed

PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome

Metabolic Syndrome x

United States
Charles University, Czech Republic

Completed

Clopidogrel Only Before Percutaneous Coronary Intervention or Before Every Coronarography?

Ischemic Heart Disease

Czech Republic
Sheba Medical Center

Completed

Clopidogrel Reloading in Clopidogrel Resistant Patients With ACS

Clopidogrel Non-Responsiveness

Israel
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

Migraine Prophylaxis With Clopidogrel Trial

Migraine

China
Novo Nordisk A/S

Completed

A Pilot Study to Determine the Impact of Clopidogrel (Plavix®) on Bleeding Associated With Punch Biopsies in Healthy Volunteers

Healthy | Haemostasis

United States
Les Laboratoires des Médicaments Stériles
University Hospital Fattouma Bourguiba

Completed

Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Body Mass Index ≥ 27 (PLATO-dose)

Cardiovascular Disease | Overweight

Tunisia
Federico II University

Unknown

Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD (LONGDAPTPAD)

Peripheral Artery Disease

Italy
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Clopidogrel and Response Variability Investigation Study 2 (CLOVIS2)

Coronary Artery Disease

France
Sanofi

Completed

Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment

Cerebral Infarction

Japan
Central Hospital, Nancy, France

Completed

Efficacy of Zoledronic Acid in Osteoporosis of Children With Multiple Disabilities (ZOMETA)

Multiple Disability | Osteoporosis

France
Eli Lilly and Company
Daiichi Sankyo, Inc.

Completed

Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event (SWAP)

Acute Coronary Syndrome | Coronary Arteriosclerosis

United States
University of Patras

Completed

Ticagrelor Loading Dose Versus Clopidogrel Loading and Reloading With Ticagrelor.

Platelet Reactivity

Greece
Shenyang Northern Hospital
Changhai Hospital; ANKON medical technologies (Shanghai)Co.,LTD

Completed

Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation (OPT-PEACE)

Ischemic Heart Disease | Gastrointestinal Injury

China

Search clinical trials for: Vorapaxar and Clopidogrel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations